Skip to main content
. Author manuscript; available in PMC: 2019 Aug 20.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2018 Mar 7;27(6):1673–1682. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.027

Figure 1.

Figure 1.

Enrollment by global region in the NAVIGATE-ESUS trial. Abbreviation: NAVIGATE-ESUS, New Approach Rivaroxaban Inhibition of Factor Xa in a Global trial vs. ASA to Prevent Embolism in Embolic Stroke of Undetermined Source.